ID

26204

Beskrivning

Study ID: 101468/125 Clinical Study ID: SKF-101468/125 Study Title: A double-blind, multicentre, flexible dose, L-dopa controlled study of ropinirole to investigate A) neuroprotective effect as measured by 3D PET scanning, and B) ophthalmological safety, in patients with early Parkinson’s disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Restless Legs Syndrome

Nyckelord

Versioner (1)
  1. 2017-10-11 2017-10-11 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

11 oktober 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

L-dopa controlled study of ropinirole, neuroprotective effect and ophthalmological safety in early Parkinson’s disease 101468/125 Module 1 Visit 2 Baseline

Engelsk

L-dopa controlled study of ropinirole, neuroprotective effect and ophthalmological safety in early Parkinson’s disease 101468/125 Module 1 Visit 2 Baseline

1 Formulär  
General Information
Beskrivning

General Information

Centre Number
Beskrivning

Centre Number

Datatyp

integer

Patient Number
Beskrivning

Patient Number

Datatyp

integer

Patient Initials
Beskrivning

Patient Initials

Datatyp

text

Visit Date
Beskrivning

Visit Date

Datatyp

date

Reminder laboratory test results: Ensure that the clinically significant laboratory values question on page 8 has been answered.
Beskrivning

Reminder laboratory test results

Datatyp

text

Vital signs
Beskrivning

Vital signs

Sitting blood pressure (systolic)
Beskrivning

Sitting blood pressure (systolic)

Datatyp

integer

Måttenheter
  • mmHg
mmHg
Sitting blood pressure (diastolic)
Beskrivning

Sitting blood pressure (diastolic)

Datatyp

integer

Måttenheter
  • mmHg
mmHg
Sitting heart rate
Beskrivning

Sitting heart rate

Datatyp

integer

Måttenheter
  • beats/min
beats/min
Baseline Adverse Experiences
Beskrivning

Baseline Adverse Experiences

Experience
Beskrivning

Experience

Datatyp

text

For SB
Beskrivning

For SB

Datatyp

text

Date Started
Beskrivning

Date Started

Datatyp

date

Date stopped
Beskrivning

Date stopped

Datatyp

date

Duration if less than 24hrs
Beskrivning

Duration if less than 24hrs

Datatyp

float

Måttenheter
  • hrs
hrs
Experience continuing at end of Baseline Visit
Beskrivning

Experience continuing at end of Baseline Visit

Datatyp

boolean

Course: Continuous
Beskrivning

Course

Datatyp

boolean

Course: If No, no of episodes
Beskrivning

Course (nr. of episodes)

Datatyp

integer

Intensity
Beskrivning

Intensity

Datatyp

integer

Corrective therapy
Beskrivning

Corrective therapy

Datatyp

text

Do you consider this a serious baseline adverse experience by the Baseline Adverse Experience Definitions
Beskrivning

Serious Baseline Adverse Experience

Datatyp

boolean

Investigator´s Signature
Beskrivning

Investigator´s Signature

Investigator´s Signature
Beskrivning

Investigator´s Signature

Datatyp

text

Date
Beskrivning

Date

Datatyp

date

Study Medication Compliance
Beskrivning

Study Medication Compliance

Has the patient been compliant with study medication? (Compliance is defined as taking between approximately 80%-120% of medication)
Beskrivning

Study Medication Compliance

Datatyp

text

Patient eligibility
Beskrivning

Patient eligibility

Patient eligibility
Beskrivning

Patient eligibility

Datatyp

boolean

Tillbaka till toppen

Similar models

L-dopa controlled study of ropinirole, neuroprotective effect and ophthalmological safety in early Parkinson’s disease 101468/125 Module 1 Visit 2 Baseline

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
General Information
Centre Number
Item
Centre Number
integer
Patient Number
Item
Patient Number
integer
Patient Initials
Item
Patient Initials
text
Visit Date
Item
Visit Date
date
Reminder laboratory test results
Item
Reminder laboratory test results: Ensure that the clinically significant laboratory values question on page 8 has been answered.
text
Item Group
Vital signs
Sitting blood pressure (systolic)
Item
Sitting blood pressure (systolic)
integer
Sitting blood pressure (diastolic)
Item
Sitting blood pressure (diastolic)
integer
Sitting heart rate
Item
Sitting heart rate
integer
Item Group
Baseline Adverse Experiences
Experience
Item
Experience
text
For SB
Item
For SB
text
Date Started
Item
Date Started
date
Date stopped
Item
Date stopped
date
Duration if less than 24hrs
Item
Duration if less than 24hrs
float
Experience continuing at end of Baseline Visit
Item
Experience continuing at end of Baseline Visit
boolean
Course
Item
Course: Continuous
boolean
Course (nr. of episodes)
Item
Course: If No, no of episodes
integer
Item
Intensity
integer
Intensity
Code List
Intensity
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
Item
Corrective therapy
text
Corrective therapy
Code List
Corrective therapy
CL Item
Yes (If "Yes" record any medication on Concomitant Medication form) (1)
CL Item
No (2)
Serious Baseline Adverse Experience
Item
Do you consider this a serious baseline adverse experience by the Baseline Adverse Experience Definitions
boolean
Item Group
Investigator´s Signature
Investigator´s Signature
Item
Investigator´s Signature
text
Date
Item
Date
date
Item Group
Study Medication Compliance
Item
Has the patient been compliant with study medication? (Compliance is defined as taking between approximately 80%-120% of medication)
text
Study Medication Compliance
Code List
Has the patient been compliant with study medication? (Compliance is defined as taking between approximately 80%-120% of medication)
CL Item
No (If "No" the patient is not eligible to continue in the study.) (1)
CL Item
Yes (2)
Item Group
Patient eligibility
Patient eligibility
Item
Patient eligibility
boolean
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial